LEHI, Utah – Nature’s Sunshine Products, Inc. (Nasdaq: NATR) (“Nature’s Sunshine” and/or the “Company”), a global leader in manufacturing and marketing high-quality herbal and nutritional supplements, reported financial results for the fourth quarter and full year ended December 31, 2025.
Summary of Q4 and Full Year 2025 Results
Q4 2025 FINANCIAL SUMMARY VS. SAME YEAR-AGO QUARTER
Net sales increased 4.7% to $123.8 million compared to $118.2 million (up 3.8% in constant currency).
GAAP net income attributable to common shareholders of $4.1 million, or $0.23 per diluted share, compared to net loss of $0.3 million, or $(0.02) per diluted share.
Adjusted EBITDA up 16% to $11.9 million compared to $10.3 million.
FULL YEAR 2025 FINANCIAL SUMMARY VS. 2024
Net sales increased 5.7% to $480.1 million compared to $454.4 million (up 5.3% in constant currency).
GAAP net income attributable to common shareholders of $19.5 million, or $1.06 per diluted share, compared to $7.7 million, or $0.40 per diluted share.
Adjusted EBITDA up 21.7% to $49.4 million compared to $40.5 million.
Click to read the detailed report on Q4 and FY 2025 for Nature’s Sunshine
Management Commentary
“We finished a record year in sales and delivered our second‑best quarter ever and our largest Q4 on record, with sales and adjusted EBITDA up 5% and 16%, respectively,”